White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy

The goal of this study was to examine the relationship between subcortical vascular disease and brain atrophy in patients with Alzheimer's disease (AD) and mixed dementia (i.e., AD and subcortical vascular disease together). MRI was performed on 77 cognitively normal (CN) subjects, 50 AD and 13 mixed dementia patients. Subcortical vascular disease was determined by white matter hyperintensities (WMH) volume and presence of subcortical lacunes. Brain atrophy was measured using total brain cortical gray matter (CGM), entorhinal cortex (ERC) and hippocampal volumes. CGM volume, but not ERC or hippocampal volume was inversely related to WMH volume in patients and controls. In contrast, no relationship was detected between CGM, ERC, or hippocampal volumes and subcortical lacunes. Furthermore, no interaction was found between WMH and diagnosis on cortical atrophy, implying that WMH affect cortical atrophy indifferently of group. These results suggest that subcortical vascular disease, manifested as WMH, may affect cortical atrophy more than ERC and hippocampal atrophy. Further, AD pathology and subcortical vascular disease may independently affect cortical atrophy.

[1]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[2]  C. Duyckaerts,et al.  The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy , 2003, Neurobiology of Aging.

[3]  K Yaffe,et al.  Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD , 2003, Neurology.

[4]  E. Rostrup,et al.  Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study , 2000, The Lancet.

[5]  Fred Plum,et al.  Temporal profile of neuronal damage in a model of transient forebrain ischemia , 1982, Annals of neurology.

[6]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.

[7]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[8]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[9]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[10]  K. Jellinger,et al.  Alzheimer disease and cerebrovascular pathology: an update , 2002, Journal of Neural Transmission.

[11]  O Nalcioglu,et al.  Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease , 1991, Neurology.

[12]  A. Hofman,et al.  Periventricular cerebral white matter lesions predict rate of cognitive decline , 2002, Annals of neurology.

[13]  N. Schuff,et al.  Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[14]  L. Thal,et al.  Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. , 2000, Archives of neurology.

[15]  R Stewart,et al.  Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam Scan Study , 2001, Neurology.

[16]  M. Weiner,et al.  Executive dysfunction in subcortical ischaemic vascular disease , 2002, Journal of neurology, neurosurgery, and psychiatry.

[17]  A Hofman,et al.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.

[18]  A. Smith,et al.  The Effects of Additional Pathology on the Cognitive Deficit in Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[19]  H. Bennett,et al.  Cognitive dysfunction following subcortical infarction. , 1994, Archives of neurology.

[20]  R. Vos,et al.  Cerebrovascular Hypoperfusion: A Risk Factor for Alzheimer's Disease? , 1997, Annals of the New York Academy of Sciences.

[21]  N. Schuff,et al.  MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease , 2001, Neurology.

[22]  J. Hatazawa,et al.  Can PET Data Differentiate Alzheimer's Disease from Vascular Dementia? , 2000, Annals of the New York Academy of Sciences.

[23]  James A. Mortimer,et al.  Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply , 1997 .

[24]  H. Soininen,et al.  MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. , 1998, AJNR. American journal of neuroradiology.

[25]  Timothy Edward John Behrens,et al.  Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging , 2003, Nature Neuroscience.

[26]  George Fein,et al.  Reliability of tissue volumes and their spatial distribution for segmented magnetic resonance images , 2001, Psychiatry Research: Neuroimaging.

[27]  M W Weiner,et al.  Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease , 2000, Neurology.

[28]  C. Jack,et al.  Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD , 2000, Neurology.

[29]  C. Loeb,et al.  Dementia Associated With Lacunar Infarction , 1992, Stroke.

[30]  C. Jack,et al.  MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.

[31]  J M Wardlaw,et al.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study: the Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.

[32]  A. Delacourte,et al.  Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? , 1991, Journal of neurology, neurosurgery, and psychiatry.

[33]  W. Jagust,et al.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.

[34]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[35]  K. Jellinger,et al.  The impact of cerebrovascular lesions in Alzheimer disease , 2003, Journal of Neurology.

[36]  H. Soininen,et al.  Volumes of the Entorhinal and Perirhinal Cortices in Alzheimer’s Disease , 1998, Neurobiology of Aging.

[37]  N. Schuff,et al.  Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus , 2002, Neurology.

[38]  Robert Moulias,et al.  Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly , 2002, Acta Neuropathologica.

[39]  C. Fisher.  Lacunar strokes and infarcts , 1982, Neurology.

[40]  J. Cervós-Navarro,et al.  Selective vulnerability in brain hypoxia. , 1991, Critical reviews in neurobiology.

[41]  F Andermann,et al.  Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging , 1992, Neurology.

[42]  Zsuzsanna Nagy,et al.  Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease , 1999, The Lancet.

[43]  J. Haxby,et al.  The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults , 1995, Neurology.